Log in

Kodiak Sciences Stock Forecast, Price & News

+3.90 (+4.07 %)
(As of 10/29/2020 12:00 AM ET)
Today's Range
Now: $99.76
50-Day Range N/A
52-Week Range
Now: $99.76
Volume307,464 shs
Average Volume334,143 shs
Market Capitalization$4.46 billion
P/E RatioN/A
Dividend YieldN/A
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:KOD
Phone650 281 0850



Sales & Book Value

Annual SalesN/A
Book Value$9.32 per share


Net Income$-47,370,000.00


Market Cap$4.46 billion
Next Earnings Date11/10/2020 (Estimated)
+3.90 (+4.07 %)
(As of 10/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KOD News and Ratings via Email

Sign-up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Kodiak Sciences (NASDAQ:KOD) Frequently Asked Questions

When is Kodiak Sciences' next earnings date?

Kodiak Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Kodiak Sciences

How were Kodiak Sciences' earnings last quarter?

Kodiak Sciences Inc. (NASDAQ:KOD) issued its earnings results on Monday, August, 10th. The company reported ($0.58) EPS for the quarter, beating the Zacks' consensus estimate of ($0.61) by $0.03.
View Kodiak Sciences' earnings history

Who are some of Kodiak Sciences' key competitors?

What other stocks do shareholders of Kodiak Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kodiak Sciences investors own include Quest Diagnostics (DGX), Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Immunomedics (IMMU), Teck Resources (TECK), Abbott Laboratories (ABT), Ability (ABIL), AbbVie (ABBV) and Axon Enterprise (AAXN).

Who are Kodiak Sciences' key executives?

Kodiak Sciences' management team includes the following people:
  • Dr. Victor Perlroth, Chairman, MD, CEO & Pres (Age 47, Pay $927.76k)
  • Mr. John A. Borgeson MBA, CPA, Sr. VP, CFO & Sec. (Age 58, Pay $635.88k)
  • Dr. Jason S. Ehrlich M.D., Ph.D., Chief Medical Officer & Chief Devel. Officer (Age 44, Pay $777.46k)
  • Dr. Hong Liang, Sr. VP of Discovery Medicine (Age 48)
  • Ms. Almas Qudrat M.Sc., Sr. VP of Quality Operations

When did Kodiak Sciences IPO?

(KOD) raised $126 million in an IPO on Thursday, October 4th 2018. The company issued 9,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Barclays and Chardan were co-managers.

What is Kodiak Sciences' stock symbol?

Kodiak Sciences trades on the NASDAQ under the ticker symbol "KOD."

How do I buy shares of Kodiak Sciences?

Shares of KOD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Kodiak Sciences' stock price today?

One share of KOD stock can currently be purchased for approximately $99.76.

How big of a company is Kodiak Sciences?

Kodiak Sciences has a market capitalization of $4.46 billion. The company earns $-47,370,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. Kodiak Sciences employs 48 workers across the globe.

What is Kodiak Sciences' official website?

The official website for Kodiak Sciences is kodiak.com.

How can I contact Kodiak Sciences?

Kodiak Sciences' mailing address is 2631 HANOVER STREET, PALO ALTO CA, 94304. The company can be reached via phone at 650 281 0850 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.